News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Relypsa, Inc. Announces Changes to Board of Directors


1/3/2013 6:50:13 AM

Relypsa, Inc., a clinical-stage biopharmaceutical company, announced today the recent appointment of two industry veterans to serve on the company’s board of directors: Paul J. Hastings, President and CEO of OncoMed Pharmaceuticals, and David W.J. McGirr, Senior Vice President and Chief Financial Officer of Cubist Pharmaceuticals.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES